Skip to main content

Month: June 2024

Form 8.3 – Mattioli Woods plc – Octopus Investments

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)        Full name of discloser: OCTOPUS INVESTMENTS LTD(b)        Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree Mattioli Woods plc(d)        If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)        Date position held/dealing...

Continue reading

Mattr Corp. Announces Renewal of Normal Course Issuer Bid

TORONTO, June 26, 2024 (GLOBE NEWSWIRE) — Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR), today announced that the Toronto Stock Exchange (the “TSX”) has approved the Company’s notice of intention to renew its normal course issuer bid (the “NCIB”) for common shares of the Company (the “Common Shares”). Pursuant to the NCIB, the Company may purchase for cancellation up to 4,982,824 Common Shares, representing approximately 10% of the Company’s public float as at June 14, 2024. As at the date hereof, the Company has 66,372,274 Common Shares issued and outstanding. The NCIB will commence on June 28, 2024 and terminate one year after its commencement, or earlier if the maximum is reached or the NCIB is terminated at the option of the Company. The Company believes that using the NCIB to return capital to its shareholders will increase...

Continue reading

Intellia Therapeutics Announces CFO Transition

CAMBRIDGE, Mass., June 26, 2024 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced the appointment of Edward Dulac as Executive Vice President, Chief Financial Officer (CFO), and Treasurer, effective July 22, 2024. Mr. Dulac will succeed Glenn Goddard who will step down from his role effective June 30, 2024. Mr. Dulac is a highly accomplished biotechnology business leader and joins Intellia with more than 20 years of combined finance, business development and corporate strategy experience. Most recently, Mr. Dulac served as CFO of Fate Therapeutics. Prior to that role, Mr. Dulac spent numerous years at Celgene (now Bristol Myers Squibb), a leading global biopharmaceutical company, where he held...

Continue reading

Altimmune Mourns Passing of Chief Financial Officer, Richard Eisenstadt

GAITHERSBURG, Md., June 26, 2024 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Richard Eisenstadt, the Company’s Chief Financial Officer, passed away unexpectedly on Monday, June 24, 2024. “We are all shocked and saddened by Rich’s passing. On behalf of everyone at Altimmune, I extend our heartfelt condolences to his family during this difficult time,” said Vipin K. Garg, Ph.D., President and Chief Executive Officer of Altimmune. “Rich was not only a brilliant and dedicated leader, but a close friend who brought a sense of wit and joy to our workplace that will be dearly missed by all who had the privilege of working with him. His unique blend of hard work and humor, along with his immeasurable contributions to our Company will continue to inspire us.” Mr. Eisenstadt’s...

Continue reading

Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update

MONTREAL, June 26, 2024 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced the Company will report financial results and provide a business update for its second quarter ended May 31, 2024, on Wednesday, July 10 at 8:30 a.m. ET. The call will be hosted by Paul Lévesque, President and Chief Executive Officer. He will be joined by other members of the management team, including Philippe Dubuc, Senior Vice President and Chief Financial Officer, Christian Marsolais, Ph.D., Senior Vice President and Chief Medical Officer and John Leasure, Global Commercial Officer who will be available to answer questions from participants following prepared remarks. Participants...

Continue reading

Amerigo Provides Update Following Heavy Rains in Chile

Limited production impact Production guidance is maintained No further rain is currently forecasted VANCOUVER, British Columbia, June 26, 2024 (GLOBE NEWSWIRE) — Amerigo Resources Ltd. (TSX: ARG; OTCQX: ARREF) (“Amerigo” or the “Company”) is providing an operational update on Minera Valle Central (“MVC”), the Company’s 100% owned operation located near Rancagua, Chile. Following the Company’s June 17, 2024 news release, Amerigo reports that heavy rains continued at MVC and have now ended. The total reported rainfall at MVC from June 13 to June 23, 2024, was 267 mm. As a reference, recent full-year precipitations were 287 mm in 2022 and 247 mm in 2021. Our power supply was unaffected, and MVC is processing fresh tailings normally. The rains caused water accumulation in the Cauquenes historic tailings deposit, halting the processing...

Continue reading

Victory Square Company Provides Corporate Update Reflecting Significant Revenue Growth & Strong Organic Operational Growth

The home healthcare market is projected to reach $340B USD by 2027 in the US alone, and Victory Square Company Hydreight is well positioned to capitalize on the rapidly growing home healthcare industry. VANCOUVER, British Columbia, June 26, 2024 (GLOBE NEWSWIRE) —  Victory Square Technologies Inc. (“Victory Square”) (CSE:VST) (OTC:VSQTF) (FWB:6F6), a company that gives investor access to a portfolio of 25+ innovative companies from around the world in a single stock, is pleased to share that its portfolio company – Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV:NURS) (OTCQB:HYDTF) (FSE:SO6) a mobile clinical network and medical platform which enables flexible, at-home medical services across the United States, is pleased to provide a corporate update reflecting its significant organic growth, increased patient...

Continue reading

Enovix Signs MOU with Leading Consumer Electronics Battery Pack Manufacturer

FREMONT, Calif., June 26, 2024 (GLOBE NEWSWIRE) — Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, today announced it has signed a Memorandum of Understanding (“MOU”) with Elentec Co., Ltd (“Elentec”) (Kosdaq: 054210: KQ), a leading consumer electronic battery pack manufacturing company in Asia serving customers such as Samsung. The agreement provides a framework for a long-term business relationship between the two companies and enables Enovix to lock in a globally trusted battery pack manufacturing partner to support its growth with target customers worldwide. The MOU allows Enovix to fast track and utilize Elentec’s battery pack design and high-volume manufacturing capability, while setting up the framework for definitive long-term supply and/or joint manufacturing agreements leveraging...

Continue reading

HPQ Silicon Affiliate — Novacium’s GEN2 Advanced Silicon-Based Anode Material Delivers Superior Performance at 100 Cycles

Testing results after 100 cycles of GEN2 material show continued strong overall capacity improvement compared to the graphite benchmark and GEN1 material, with minimal cycle degradation [1].MONTRÉAL, June 26, 2024 (GLOBE NEWSWIRE) — HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ) (OTCQB: HPQFF) (FRA: O08), a technology company specializing in green engineering of silica and silicon-based materials is pleased to announce the latest battery milestones achieved by its France-based affiliate, NOVACIUM SAS (“Novacium”). This announcement highlights the continuation of the remarkable results obtained during the cycle tests of 18650 industrial batteries made with Novacium’s non-optimized second-generation advanced silicon-based anode material over 100 cycles. “These results continue to showcase our capability to...

Continue reading

Daktronics, Inc. Announces Record Fiscal Year and Fourth Quarter 2024 Revenue and Strong Expansion in Operating Profitability and Cash Flow

BROOKINGS, S.D., June 26, 2024 (GLOBE NEWSWIRE) — Daktronics, Inc. (NASDAQ – DAKT), the leading U.S.-based designer and manufacturer of best-in-class dynamic video communication displays and control systems for customers worldwide, today reported results for its fiscal year and fourth quarter 2024 ended on April 27, 2024. Fiscal Q4 and full year 2024 financial highlights:Sales increased to a new record of $215.9 million for the fiscal fourth quarter, a 2.9 percent increase compared to the fiscal 2024 fourth quarter’s record revenue; full-year sales were $818.1 million, an 8.5 percent increase from the prior year Gross margin for the fourth quarter improved 90 basis points to 25.7 percent from 24.8 percent in the year-earlier period; full year gross profit as a percentage of net sales increased 710 basis points to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.